+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genome Engineering Market - Global Forecast 2026-2032- Product Image
Genome Engineering Market - Global Forecast 2026-2032- Product Image
Sale

Genome Engineering Market - Global Forecast 2026-2032

  • Report

  • 198 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4904586
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Genome Engineering Market is projected to reach USD 9.83 Billion in 2026. It is expected to continue growing at a CAGR of 16.17%, reaching USD 24.24 Billion by 2032.

Genome engineering is moving from a research-intensive discipline into a commercially validated pillar of precision medicine, biomanufacturing, agriculture, and synthetic biology. The field is anchored by CRISPR-Cas systems, base editing, prime editing, zinc finger nucleases, TALENs, viral and non-viral delivery platforms, and increasingly automated design-build-test-learn workflows.

Commercial momentum has accelerated as regulators began approving CRISPR-based therapies. The United Kingdom authorized the first CRISPR-based therapy in November 2023, followed by the United States in December 2023 for sickle cell disease, marking a major milestone for therapeutic genome editing. This validation is expanding strategic interest across cell and gene therapy, oncology, rare disease, infectious disease research, crop trait development, and industrial biotechnology.

Transformative Shifts in the Genome Engineering Landscape

The genome engineering landscape is being reshaped by the convergence of programmable nucleases, high-throughput sequencing, improved delivery systems, and cloud-enabled computational biology. CRISPR-Cas9 remains the most widely adopted platform, while base editing and prime editing are gaining attention because they may enable more precise edits without relying on double-strand DNA breaks.

The market is also shifting from tool adoption toward integrated platforms. Buyers increasingly evaluate end-to-end capabilities, including guide RNA design, off-target analysis, cell engineering, analytical validation, GMP manufacturing readiness, and regulatory documentation. This is raising the competitive importance of quality systems, reproducibility, data integrity, intellectual property strategy, and scalable delivery technologies.

Cumulative Impact of Artificial Intelligence on Genome Engineering

Artificial intelligence is becoming a foundational layer for genome engineering because it can accelerate target discovery, guide RNA selection, protein engineering, and off-target risk prediction. AI models trained on genomic, transcriptomic, proteomic, and clinical datasets are helping researchers prioritize edits and reduce experimental cycles.

A defining proof point is the broad availability of predicted protein structures through resources such as the AlphaFold Protein Structure Database, which expanded structural biology access at unprecedented scale. In genome engineering, similar AI-enabled approaches are improving enzyme discovery, CRISPR variant design, delivery-vector optimization, and cell-line engineering, while also increasing the need for transparent model validation and responsible data governance.

Key Regional Insights Across the Genome Engineering Market

Asia-Pacific is gaining importance through China, Japan, South Korea, India, Singapore, and Australia, where national biotechnology strategies, expanding sequencing capacity, and strong academic pipelines support genome engineering adoption. China has a large clinical research ecosystem for cell and gene therapy, Japan and South Korea emphasize advanced therapeutics and regenerative medicine, India is scaling biotech capacity through national bioeconomy initiatives, and Australia remains active in translational genomics and clinical research.

North America remains a global anchor for genome engineering commercialization, supported by the United States and Canada, deep venture capital networks, leading universities, FDA regulatory pathways, and a mature biopharma ecosystem. Europe is differentiated by strong research infrastructure, Horizon Europe funding, EMA oversight, and national genomics programs, while Latin America is emerging through Brazil and Mexico in agricultural biotechnology, public health genomics, and research partnerships. The Middle East is building genomics capacity through precision medicine programs, and Africa is advancing genomics through infectious disease surveillance, agriculture, and regional research networks supported by pathogen genomics and public health initiatives.

Key Group Insights for Genome Engineering Adoption

ASEAN is becoming more relevant as Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines invest in biotechnology, precision medicine, and agricultural innovation. Singapore is the region's strongest translational hub, while broader ASEAN demand is supported by food security priorities, disease surveillance, and expanding life sciences infrastructure.

The GCC is prioritizing genomics as part of healthcare modernization, particularly through national genome programs and precision medicine investments in Saudi Arabia, the United Arab Emirates, and Qatar. The European Union combines strong research funding with rigorous governance for advanced therapies and genetically modified organisms. BRICS nations represent scale, biodiversity, clinical research depth, and manufacturing potential, while the G7 continues to lead in regulatory science, intellectual property, advanced biomanufacturing, and clinical translation. NATO countries add relevance through biosecurity, supply chain resilience, pathogen surveillance, and dual-use technology governance.

Key Country Insights Across Leading Genome Engineering Markets

The United States leads in genome engineering commercialization due to FDA-approved gene-editing therapies, a dense venture ecosystem, major academic medical centers, and advanced CRISPR, cell therapy, and synthetic biology capabilities. Canada is active in stem cell research, genomics, and biomanufacturing, while Mexico is building biotechnology capacity linked to healthcare, agriculture, and North American supply chains. Brazil is a major Latin American hub for agricultural biotechnology, biodiversity research, and biomedical innovation.

In Europe, the United Kingdom has demonstrated regulatory leadership through early authorization of a CRISPR-based therapy, while Germany and France remain central to life sciences R&D, diagnostics, and biomanufacturing. Italy and Spain contribute strong clinical research and translational medicine capabilities, and Russia maintains scientific capacity in genetics and molecular biology despite geopolitical constraints. In Asia-Pacific, China is one of the largest genome engineering research markets, India is scaling biotech and vaccine manufacturing strength, Japan is advanced in regenerative medicine and precision health, Australia is strong in genomics-led clinical research, and South Korea combines biomanufacturing scale with advanced therapeutics investment.

Actionable Recommendations for Genome Engineering Leaders

Industry leaders should prioritize clinically and commercially validated use cases, especially where genome engineering offers measurable advantages over conventional modalities. Strategic focus areas include ex vivo cell therapy, in vivo editing delivery, rare disease programs, oncology applications, functional genomics, engineered cell lines, and climate-resilient crops.

Organizations should strengthen AI-enabled design capabilities, invest in off-target and long-read sequencing validation, secure freedom-to-operate assessments, and build regulatory-ready data packages early. Partnerships with academic centers, contract development and manufacturing organizations, sequencing providers, and cloud bioinformatics platforms can reduce development risk and improve scalability.

Research Methodology

This executive summary is based on a structured secondary research approach using verified public sources, including regulatory agency announcements, peer-reviewed scientific literature, clinical trial registries, patent landscapes, government biotechnology strategies, and recognized genomics and structural biology databases.

Insights were synthesized through market triangulation across technology adoption, regulatory milestones, regional policy signals, funding activity, clinical translation, and application-level demand. The analysis emphasizes data-backed developments and avoids unsupported market sizing where independently verifiable figures are not available.

Conclusion

Genome engineering has entered a new phase defined by regulatory validation, rapid platform innovation, and broader adoption across healthcare, agriculture, and industrial biotechnology. CRISPR-based approvals have shifted the field from scientific promise to therapeutic precedent, while AI and automation are improving speed, accuracy, and scalability.

The next stage of competition will be shaped by delivery performance, safety evidence, manufacturing readiness, data governance, intellectual property strength, and global regulatory alignment. Organizations that combine scientific rigor with scalable platforms and responsible commercialization will be best positioned to lead the genome engineering market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Genome Engineering Market, by Offering
7.1. Introduction
7.2. Instruments
7.2.1. Electroporation Systems
7.2.2. Microinjection Systems
7.3. Reagents & Consumables
7.3.1. Delivery Reagents
7.3.2. Kits & Enzymes
7.4. Software
7.4.1. Data Analysis
7.4.2. Design
7.5. Services
7.5.1. Screening
7.5.2. Assay Development
8. Genome Engineering Market, by Technology
8.1. Introduction
8.2. CRISPR Systems
8.2.1. CRISPR/Cas12
8.2.2. CRISPR/Cas9
8.3. Meganucleases
8.4. Transcription Control
9. Genome Engineering Market, by Delivery Method
9.1. Introduction
9.2. Ex-vivo
9.3. In-vivo
10. Genome Engineering Market, by Application
10.1. Introduction
10.2. Genetic Engineering
10.3. Clinical Therapeutics
10.4. Research & Discovery
11. Genome Engineering Market, by End User
11.1. Introduction
11.2. Academic & Research Institutes
11.3. Contract Research Organizations
11.4. Pharmaceutical & Biotechnology Companies
12. Genome Engineering Market, by Region
12.1. Asia-Pacific
12.2. North America
12.3. Latin America
12.4. Europe
12.5. Middle East
12.6. Africa
13. Genome Engineering Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Genome Engineering Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. AgBiome, Inc.
16.2. Agilent Technologies, Inc.
16.3. BASF SE
16.4. Bayer AG
16.5. Beam Therapeutics
16.6. Bio-Rad Laboratories, Inc.
16.7. Charles River Laboratories Inc.
16.8. Cibus Inc.
16.9. Clinisys, Inc.
16.10. Corteva Agriscience
16.11. Creative Biogene
16.12. CRISPR Therapeutics AG
16.13. Danaher Corporation
16.14. GenScript Biotech Corporation
16.15. Groupe Limagrain Holding
16.16. Intellia Therapeutics, Inc.
16.17. Lonza Group AG
16.18. Merck KGaA
16.19. New England Biolabs
16.20. QIAGEN N.V.
16.21. Revvity Inc.
16.22. Synthego Holdings LLC
16.23. Takara Bio Inc.
16.24. Thermo Fisher Scientific Inc.
16.25. Twist Bioscience
List of Figures
FIGURE 1. GLOBAL GENOME ENGINEERING MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL GENOME ENGINEERING MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL GENOME ENGINEERING MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL GENOME ENGINEERING MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL GENOME ENGINEERING MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL GENOME ENGINEERING MARKET SIZE, BY OFFERING, 2025 VS 2032 (%)
FIGURE 7. GLOBAL GENOME ENGINEERING MARKET SIZE, BY OFFERING, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 9. GLOBAL GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL GENOME ENGINEERING MARKET SIZE, BY DELIVERY METHOD, 2025 VS 2032 (%)
FIGURE 11. GLOBAL GENOME ENGINEERING MARKET SIZE, BY DELIVERY METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL GENOME ENGINEERING MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL GENOME ENGINEERING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL GENOME ENGINEERING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL GENOME ENGINEERING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL GENOME ENGINEERING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL GENOME ENGINEERING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL GENOME ENGINEERING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL GENOME ENGINEERING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL GENOME ENGINEERING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL GENOME ENGINEERING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL GENOME ENGINEERING MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL GENOME ENGINEERING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL GENOME ENGINEERING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL ELECTROPORATION SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL ELECTROPORATION SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL ELECTROPORATION SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL MICROINJECTION SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL MICROINJECTION SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL MICROINJECTION SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL REAGENTS & CONSUMABLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL DELIVERY REAGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL DELIVERY REAGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL DELIVERY REAGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL KITS & ENZYMES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL KITS & ENZYMES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL KITS & ENZYMES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL SOFTWARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL SOFTWARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL SOFTWARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL DATA ANALYSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL DATA ANALYSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL DATA ANALYSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL DESIGN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL DESIGN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL DESIGN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL SCREENING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL SCREENING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL SCREENING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL ASSAY DEVELOPMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL ASSAY DEVELOPMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL ASSAY DEVELOPMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL CRISPR SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL CRISPR SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL CRISPR SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL CRISPR/CAS12 MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL CRISPR/CAS12 MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL CRISPR/CAS12 MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL CRISPR/CAS9 MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL CRISPR/CAS9 MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL CRISPR/CAS9 MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL MEGANUCLEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL MEGANUCLEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL MEGANUCLEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL TRANSCRIPTION CONTROL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL TRANSCRIPTION CONTROL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL TRANSCRIPTION CONTROL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL GENOME ENGINEERING MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL EX-VIVO MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL EX-VIVO MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL EX-VIVO MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL IN-VIVO MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL IN-VIVO MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL IN-VIVO MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL GENETIC ENGINEERING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL GENETIC ENGINEERING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL GENETIC ENGINEERING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL CLINICAL THERAPEUTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL CLINICAL THERAPEUTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL CLINICAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL RESEARCH & DISCOVERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL RESEARCH & DISCOVERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL RESEARCH & DISCOVERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL GENOME ENGINEERING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL GENOME ENGINEERING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. ASIA-PACIFIC GENOME ENGINEERING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 85. ASIA-PACIFIC GENOME ENGINEERING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 86. ASIA-PACIFIC GENOME ENGINEERING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 87. ASIA-PACIFIC GENOME ENGINEERING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 88. ASIA-PACIFIC GENOME ENGINEERING MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 89. ASIA-PACIFIC GENOME ENGINEERING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 90. ASIA-PACIFIC GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 91. ASIA-PACIFIC GENOME ENGINEERING MARKET SIZE, BY CRISPR SYSTEMS, 2017-2032 (USD MILLION)
TABLE 92. ASIA-PACIFIC GENOME ENGINEERING MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 93. ASIA-PACIFIC GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 94. ASIA-PACIFIC GENOME ENGINEERING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 95. NORTH AMERICA GENOME ENGINEERING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. NORTH AMERICA GENOME ENGINEERING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 97. NORTH AMERICA GENOME ENGINEERING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 98. NORTH AMERICA GENOME ENGINEERING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 99. NORTH AMERICA GENOME ENGINEERING MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 100. NORTH AMERICA GENOME ENGINEERING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 101. NORTH AMERICA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 102. NORTH AMERICA GENOME ENGINEERING MARKET SIZE, BY CRISPR SYSTEMS, 2017-2032 (USD MILLION)
TABLE 103. NORTH AMERICA GENOME ENGINEERING MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 104. NORTH AMERICA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 105. NORTH AMERICA GENOME ENGINEERING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 106. LATIN AMERICA GENOME ENGINEERING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 107. LATIN AMERICA GENOME ENGINEERING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 108. LATIN AMERICA GENOME ENGINEERING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 109. LATIN AMERICA GENOME ENGINEERING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 110. LATIN AMERICA GENOME ENGINEERING MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 111. LATIN AMERICA GENOME ENGINEERING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 112. LATIN AMERICA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 113. LATIN AMERICA GENOME ENGINEERING MARKET SIZE, BY CRISPR SYSTEMS, 2017-2032 (USD MILLION)
TABLE 114. LATIN AMERICA GENOME ENGINEERING MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 115. LATIN AMERICA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 116. LATIN AMERICA GENOME ENGINEERING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 117. EUROPE GENOME ENGINEERING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 118. EUROPE GENOME ENGINEERING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 119. EUROPE GENOME ENGINEERING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 120. EUROPE GENOME ENGINEERING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 121. EUROPE GENOME ENGINEERING MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 122. EUROPE GENOME ENGINEERING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 123. EUROPE GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 124. EUROPE GENOME ENGINEERING MARKET SIZE, BY CRISPR SYSTEMS, 2017-2032 (USD MILLION)
TABLE 125. EUROPE GENOME ENGINEERING MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 126. EUROPE GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 127. EUROPE GENOME ENGINEERING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 128. MIDDLE EAST GENOME ENGINEERING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 129. MIDDLE EAST GENOME ENGINEERING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 130. MIDDLE EAST GENOME ENGINEERING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 131. MIDDLE EAST GENOME ENGINEERING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 132. MIDDLE EAST GENOME ENGINEERING MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 133. MIDDLE EAST GENOME ENGINEERING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 134. MIDDLE EAST GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 135. MIDDLE EAST GENOME ENGINEERING MARKET SIZE, BY CRISPR SYSTEMS, 2017-2032 (USD MILLION)
TABLE 136. MIDDLE EAST GENOME ENGINEERING MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 137. MIDDLE EAST GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 138. MIDDLE EAST GENOME ENGINEERING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 139. AFRICA GENOME ENGINEERING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 140. AFRICA GENOME ENGINEERING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 141. AFRICA GENOME ENGINEERING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 142. AFRICA GENOME ENGINEERING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 143. AFRICA GENOME ENGINEERING MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 144. AFRICA GENOME ENGINEERING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 145. AFRICA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 146. AFRICA GENOME ENGINEERING MARKET SIZE, BY CRISPR SYSTEMS, 2017-2032 (USD MILLION)
TABLE 147. AFRICA GENOME ENGINEERING MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 148. AFRICA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 149. AFRICA GENOME ENGINEERING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 150. GLOBAL GENOME ENGINEERING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 151. ASEAN GENOME ENGINEERING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 152. ASEAN GENOME ENGINEERING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 153. ASEAN GENOME ENGINEERING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 154. ASEAN GENOME ENGINEERING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 155. ASEAN GENOME ENGINEERING MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 156. ASEAN GENOME ENGINEERING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 157. ASEAN GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 158. ASEAN GENOME ENGINEERING MARKET SIZE, BY CRISPR SYSTEMS, 2017-2032 (USD MILLION)
TABLE 159. ASEAN GENOME ENGINEERING MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 160. ASEAN GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 161. ASEAN GENOME ENGINEERING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 162. GCC GENOME ENGINEERING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 163. GCC GENOME ENGINEERING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 164. GCC GENOME ENGINEERING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 165. GCC GENOME ENGINEERING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 166. GCC GENOME ENGINEERING MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 167. GCC GENOME ENGINEERING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 168. GCC GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 169. GCC GENOME ENGINEERING MARKET SIZE, BY CRISPR SYSTEMS, 2017-2032 (USD MILLION)
TABLE 170. GCC GENOME ENGINEERING MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 171. GCC GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 172. GCC GENOME ENGINEERING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 173. EUROPEAN UNION GENOME ENGINEERING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 174. EUROPEAN UNION GENOME ENGINEERING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 175. EUROPEAN UNION GENOME ENGINEERING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 176. EUROPEAN UNION GENOME ENGINEERING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 177. EUROPEAN UNION GENOME ENGINEERING MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 178. EUROPEAN UNION GENOME ENGINEERING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 179. EUROPEAN UNION GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 180. EUROPEAN UNION GENOME ENGINEERING MARKET SIZE, BY CRISPR SYSTEMS, 2017-2032 (USD MILLION)
TABLE 181. EUROPEAN UNION GENOME ENGINEERING MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 182. EUROPEAN UNION GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 183. EUROPEAN UNION GENOME ENGINEERING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 184. BRICS GENOME ENGINEERING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 185. BRICS GENOME ENGINEERING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 186. BRICS GENOME ENGINEERING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 187. BRICS GENOME ENGINEERING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 188. BRICS GENOME ENGINEERING MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 189. BRICS GENOME ENGINEERING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 190. BRICS GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 191. BRICS GENOME ENGINEERING MARKET SIZE, BY CRISPR SYSTEMS, 2017-2032 (USD MILLION)
TABLE 192. BRICS GENOME ENGINEERING MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 193. BRICS GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 194. BRICS GENOME ENGINEERING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 195. G7 GENOME ENGINEERING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 196. G7 GENOME ENGINEERING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 197. G7 GENOME ENGINEERING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 198. G7 GENOME ENGINEERING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 199. G7 GENOME ENGINEERING MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 200. G7 GENOME ENGINEERING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 201. G7 GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 202. G7 GENOME ENGINEERING MARKET SIZE, BY CRISPR SYSTEMS, 2017-2032 (USD MILLION)
TABLE 203. G7 GENOME ENGINEERING MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 204. G7 GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 205. G7 GENOME ENGINEERING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 206. NATO GENOME ENGINEERING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 207. NATO GENOME ENGINEERING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 208. NATO GENOME ENGINEERING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 209. NATO GENOME ENGINEERING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 210. NATO GENOME ENGINEERING MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 211. NATO GENOME ENGINEERING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 212. NATO GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 213. NATO GENOME ENGINEERING MARKET SIZE, BY CRISPR SYSTEMS, 2017-2032 (USD MILLION)
TABLE 214. NATO GENOME ENGINEERING MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 215. NATO GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 216. NATO GENOME ENGINEERING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 217. GLOBAL GENOME ENGINEERING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 218. UNITED STATES GENOME ENGINEERING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 219. UNITED STATES GENOME ENGINEERING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 220. UNITED STATES GENOME ENGINEERING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 221. UNITED STATES GENOME ENGINEERING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 222. UNITED STATES GENOME ENGINEERING MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 223. UNITED STATES GENOME ENGINEERING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 224. UNITED STATES GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 225. UNITED STATES GENOME ENGINEERING MARKET SIZE, BY CRISPR SYSTEMS, 2017-2032 (USD MILLION)
TABLE 226. UNITED STATES GENOME ENGINEERING MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 227. UNITED STATES GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 228. UNITED STATES GENOME ENGINEERING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 229. CANADA GENOME ENGINEERING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 230. CANADA GENOME ENGINEERING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 231. CANADA GENOME ENGINEERING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 232. CANADA GENOME ENGINEERING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 233. CANADA GENOME ENGINEERING MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 234. CANADA GENOME ENGINEERING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 235. CANADA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 236. CANADA GENOME ENGINEERING MARKET SIZE, BY CRISPR SYSTEMS, 2017-2032 (USD MILLION)
TABLE 237. CANADA GENOME ENGINEERING MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 238. CANADA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 239. CANADA GENOME ENGINEERING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 240. MEXICO GENOME ENGINEERING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 241. MEXICO GENOME ENGINEERING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 242. MEXICO GENOME ENGINEERING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 243. MEXICO GENOME ENGINEERING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 244. MEXICO GENOME ENGINEERING MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 245. MEXICO GENOME ENGINEERING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 246. MEXICO GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 247. MEXICO GENOME ENGINEERING MARKET SIZE, BY CRISPR SYSTEMS, 2017-2032 (USD MILLION)
TABLE 248. MEXICO GENOME ENGINEERING MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 249. MEXICO GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 250. MEXICO GENOME ENGINEERING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 251. BRAZIL GENOME ENGINEERING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 252. BRAZIL GENOME ENGINEERING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 253. BRAZIL GENOME ENGINEERING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 254. BRAZIL GENOME ENGINEERING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 255. BRAZIL GENOME ENGINEERING MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 256. BRAZIL GENOME ENGINEERING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 257. BRAZIL GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 258. BRAZIL GENOME ENGINEERING MARKET SIZE, BY CRISPR SYSTEMS, 2017-2032 (USD MILLION)
TABLE 259. BRAZIL GENOME ENGINEERING MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 260. BRAZIL GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 261. BRAZIL GENOME ENGINEERING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 262. UNITED KINGDOM GENOME ENGINEERING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 263. UNITED KINGDOM GENOME ENGINEERING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 264. UNITED KINGDOM GENOME ENGINEERING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 265. UNITED KINGDOM GENOME ENGINEERING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 266. UNITED KINGDOM GENOME ENGINEERING MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 267. UNITED KINGDOM GENOME ENGINEERING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 268. UNITED KINGDOM GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 269. UNITED KINGDOM GENOME ENGINEERING MARKET SIZE, BY CRISPR SYSTEMS, 2017-2032 (USD MILLION)
TABLE 270. UNITED KINGDOM GENOME ENGINEERING MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 271. UNITED KINGDOM GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 272. UNITED KINGDOM GENOME ENGINEERING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 273. GERMANY GENOME ENGINEERING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 274. GERMANY GENOME ENGINEERING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 275. GERMANY GENOME ENGINEERING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 276. GERMANY GENOME ENGINEERING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 277. GERMANY GENOME ENGINEERING MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 278. GERMANY GENOME ENGINEERING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 279. GERMANY GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 280. GERMANY GENOME ENGINEERING MARKET SIZE, BY CRISPR SYSTEMS, 2017-2032 (USD MILLION)
TABLE 281. GERMANY GENOME ENGINEERING MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 282. GERMANY GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 283. GERMANY GENOME ENGINEERING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 284. FRANCE GENOME ENGINEERING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 285. FRANCE GENOME ENGINEERING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 286. FRANCE GENOME ENGINEERING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 287. FRANCE GENOME ENGINEERING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 288. FRANCE GENOME ENGINEERING MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 289. FRANCE GENOME ENGINEERING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 290. FRANCE GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 291. FRANCE GENOME ENGINEERING MARKET SIZE, BY CRISPR SYSTEMS, 2017-2032 (USD MILLION)
TABLE 292. FRANCE GENOME ENGINEERING MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 293. FRANCE GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 294. FRANCE GENOME ENGINEERING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 295. RUSSIA GENOME ENGINEERING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 296. RUSSIA GENOME ENGINEERING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 297. RUSSIA GENOME ENGINEERING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 298. RUSSIA GENOME ENGINEERING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 299. RUSSIA GENOME ENGINEERING MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 300. RUSSIA GENOME ENGINEERING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 301. RUSSIA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 302. RUSSIA GENOME ENGINEERING MARKET SIZE, BY CRISPR SYSTEMS, 2017-2032 (USD MILLION)
TABLE 303. RUSSIA GENOME ENGINEERING MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 304. RUSSIA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 305. RUSSIA GENOME ENGINEERING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 306. ITALY GENOME ENGINEERING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 307. ITALY GENOME ENGINEERING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 308. ITALY GENOME ENGINEERING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 309. ITALY GENOME ENGINEERING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 310. ITALY GENOME ENGINEERING MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 311. ITALY GENOME ENGINEERING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 312. ITALY GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 313. ITALY GENOME ENGINEERING MARKET SIZE, BY CRISPR SYSTEMS, 2017-2032 (USD MILLION)
TABLE 314. ITALY GENOME ENGINEERING MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 315. ITALY GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 316. ITALY GENOME ENGINEERING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 317. SPAIN GENOME ENGINEERING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 318. SPAIN GENOME ENGINEERING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 319. SPAIN GENOME ENGINEERING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 320. SPAIN GENOME ENGINEERING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 321. SPAIN GENOME ENGINEERING MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 322. SPAIN GENOME ENGINEERING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 323. SPAIN GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 324. SPAIN GENOME ENGINEERING MARKET SIZE, BY CRISPR SYSTEMS, 2017-2032 (USD MILLION)
TABLE 325. SPAIN GENOME ENGINEERING MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 326. SPAIN GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 327. SPAIN GENOME ENGINEERING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 328. CHINA GENOME ENGINEERING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 329. CHINA GENOME ENGINEERING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 330. CHINA GENOME ENGINEERING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 331. CHINA GENOME ENGINEERING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 332. CHINA GENOME ENGINEERING MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 333. CHINA GENOME ENGINEERING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 334. CHINA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 335. CHINA GENOME ENGINEERING MARKET SIZE, BY CRISPR SYSTEMS, 2017-2032 (USD MILLION)
TABLE 336. CHINA GENOME ENGINEERING MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 337. CHINA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 338. CHINA GENOME ENGINEERING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 339. INDIA GENOME ENGINEERING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 340. INDIA GENOME ENGINEERING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 341. INDIA GENOME ENGINEERING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 342. INDIA GENOME ENGINEERING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 343. INDIA GENOME ENGINEERING MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 344. INDIA GENOME ENGINEERING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 345. INDIA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 346. INDIA GENOME ENGINEERING MARKET SIZE, BY CRISPR SYSTEMS, 2017-2032 (USD MILLION)
TABLE 347. INDIA GENOME ENGINEERING MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 348. INDIA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 349. INDIA GENOME ENGINEERING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 350. JAPAN GENOME ENGINEERING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 351. JAPAN GENOME ENGINEERING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 352. JAPAN GENOME ENGINEERING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 353. JAPAN GENOME ENGINEERING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 354. JAPAN GENOME ENGINEERING MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 355. JAPAN GENOME ENGINEERING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 356. JAPAN GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 357. JAPAN GENOME ENGINEERING MARKET SIZE, BY CRISPR SYSTEMS, 2017-2032 (USD MILLION)
TABLE 358. JAPAN GENOME ENGINEERING MARKET SIZE, BY DELIVERY METHOD, 2017-2032 (USD MILLION)
TABLE 359. JAPAN GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 360. JAPAN GENOME ENGINEERING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 361. AUSTRALIA GENOME ENGINEERING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 362. AUSTRALIA GENOME ENGINEERING MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 363. AUSTRALIA GENOME ENGINEERING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 364. AUSTRALIA GENOME ENGINEERING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 365. AUSTRALIA GENOME ENGINEERING MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 366. AUSTRALIA GENOME ENGINEERING MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 367. AUSTRALIA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 368. AUSTRALIA GENOME ENGINEERING MARKET SIZE, BY CRISPR SYSTEMS, 2017-2032 (USD MILLION)
TABLE 369. AUSTRALIA GENOME ENGINEERING MARKET SIZE, BY DELI

Companies Mentioned

  • AgBiome, Inc.
  • Agilent Technologies, Inc.
  • BASF SE
  • Bayer AG
  • Beam Therapeutics
  • Bio-Rad Laboratories, Inc.
  • Charles River Laboratories Inc.
  • Cibus Inc.
  • Clinisys, Inc.
  • Corteva Agriscience
  • Creative Biogene
  • CRISPR Therapeutics AG
  • Danaher Corporation
  • GenScript Biotech Corporation
  • Groupe Limagrain Holding
  • Intellia Therapeutics, Inc.
  • Lonza Group AG
  • Merck KGaA
  • New England Biolabs
  • QIAGEN N.V.
  • Revvity Inc.
  • Synthego Holdings LLC
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience

Table Information

Report AttributeDetails
No. of Pages198
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 9.83 Billion
Forecasted Market Value ( USD ) by 2032 $ 24.24 Billion
Compound Annual Growth Rate16.1%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Mutation Detection Kits In Genome Editing Market - Global Forecast 2026-2032 - Product Image

Mutation Detection Kits In Genome Editing Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
Genome Editing Market - Global Forecast 2026-2032 - Product Image

Genome Editing Market - Global Forecast 2026-2032

  • Report
  • 193 Pages
  • Global
From
Genome Editing Market Size, Share & Trends Analysis Report by Technology (CRISPR/Cas9, ZFN), Delivery Method (Ex Vivo, in Vivo), Application (Genetic Engineering, Clinical Applications), Mode, End Use, and Region with Growth Forecasts, 2026-2033 - Product Image

Genome Editing Market Size, Share & Trends Analysis Report by Technology (CRISPR/Cas9, ZFN), Delivery Method (Ex Vivo, in Vivo), Application (Genetic Engineering, Clinical Applications), Mode, End Use, and Region with Growth Forecasts, 2026-2033

  • Report
  • 120 Pages
  • Global
From
Single-Cell Genome Sequencing - Global Strategic Business Report - Product Image

Single-Cell Genome Sequencing - Global Strategic Business Report

  • Report
  • 222 Pages
  • Global
From
Genome Editing/Genome Engineering Market Report 2026 - Product Image

Genome Editing/Genome Engineering Market Report 2026

  • Report
  • 250 Pages
  • Global
From

About the Genome Engineering Market

The Genome Engineering market is a subset of the larger Genomics industry, which focuses on the study of genomes and their functions. Genome Engineering is the process of manipulating the genetic material of an organism to modify its characteristics. This includes techniques such as gene editing, gene therapy, and gene regulation. It is used in a variety of applications, including agriculture, biotechnology, and medicine. Genome Engineering has seen rapid growth in recent years, driven by advances in technology and the increasing availability of data. This has enabled researchers to develop more precise and efficient methods for manipulating genetic material. As a result, the market is expected to continue to expand in the coming years. Some of the major players in the Genome Engineering market include Editas Medicine, CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences, and Sangamo Therapeutics. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.